ArticleChemistry & biodiversity2025
The Phenolic Content and Bioactivity Assessment of Rubus sanctus Schreber Species with Potential for Food and Ethnopharmacological Uses.
Article in Chemistry & biodiversity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Tissue-Specific Phytochemical Profiling and Bioactivity of Ricinus communis L. Under Varying Agronomic Conditions.Chemistry & biodiversity · 2026Article
- Therapeutic Insights intoPharmaceuticals (Basel, Switzerland) · 2025Article
- The Phenolic Content and Bioactivity Assessment of Rubus sanctus Schreber Species with Potential for Food and Ethnopharmacological Uses.Chemistry & biodiversity · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, the phytochemical content and various biological activities of Rubus sanctus Schreber species, widely distributed in Turkiye and used in folk medicine, were determined. The ethanol extracts of the root and aerial parts of the species were prepared and their bioactive phytochemical composition was identified by liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and gas chromatography-mass spectrometry (GC-MS) techniques. Furthermore, various antioxidant tests and enzyme inhibition tests were applied to reveal the bioactivity of the species. According to the LC-MS/MS results, the main components of the species were determined as epicatechin (root: 78.370 and aerial part; 45.358 mg analyte/g extract), ellagic acid (root: 41.179, aerial part: 33.679), and miquelianin (root: 23.566, aerial part; 11.560). In compliance with the GC-MS results, it was determined that the species merely contained oleanolic acid (aerial part; 4.460 mg analyte/g extract) as triterpene. The analysis of the antioxidant tests revealed that the species' root and aerial parts showed the greatest activity and a high antioxidant capacity, particularly in the cupric reducing antioxidant capacity test method (A
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.